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Abstract
Background: Asthma is recognized as intimately related to immunologic factors and inflammation, although there
are likely multiple phenotypes and pathophysiologic pathways. Biomarkers of inflammation may shed light on
causal factors and have potential clinical utility. Individual and population genetic factors are correlated with
risk for asthma and improved understanding of these contributions could improve treatment and prevention
of this serious condition.
Methods: A population-based sample of 108 children with clinically defined asthma and 216 control children
were recruited from a small community in the northern plains of the United States. A complete blood count,
high sensitivity C-reactive protein, total IgE and specific antibodies to 5 common airborne antigens (CAA), in
addition to basic demographic and anthropomorphic data were obtained. Logistic regression was primarily
used to determine the association between these humoral factors and risk of asthma.
Results: The body mass index (BMI) of those with asthma and their total leukocyte counts, percentage of
eosinophils, and levels of total IgE were all greater than corresponding control values in univariate analysis.
The presence of detectable, specific IgE antibodies to five common airborne antigens was more likely among
cases compared with controls. In multivariate analysis, total IgE was independently associated with asthma;
but not after inclusion of a cumulative measure of specific IgE sensitization.
Conclusion: Many previously reported associations between anthropomorphic and immune factors and
increased risk of asthma appear to be also present in this American Indian population. In this community,
asthma is strongly associated with sensitization to CAA.
Keywords: Asthma, Airborne allergens, Immunoglobulin, IgE, Allergen specific IgE, C-reactive protein,
Eosinophils, American Indian, Children
Background
Asthma has long been recognized as intimately related
to immunologic factors and inflammation [1]. Clinically
there appear to be a number of asthma “phenotypes”,
with those involving inflammation and immune response
ranging from very acute, specific reactions to animal
dander for example, to more subtle, low-level degrees of
chronic inflammation [2]. To inform therapies, there has
been a concerted effort to discover and evaluate various
biomarkers of inflammation in general, as well as innate
and specific, adaptive immunity [3]. Initial attempts to
characterize inflammation showed that crude measures,
such as neutrophil count [4] and proportion of eosino-
phils [5] are associated with asthma. Later, the measure-
ment of total immunoglobulin E (IgE) [6] and then
specific immunoglobulins targeting particular exposures,
such as certain insect and rodent species was found to
be informative [7]. Most recently very detailed and
specific components of the inflammatory and immune
response are being explored [3].
The complex interplay between the immune system
and environmental exposures precludes any simplistic
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models of asthma pathophysiology; and makes infer-
ences from epidemiologic data difficult. Thus the differ-
ing ecological and socio-economic environment of
populations can produce characteristic profiles of vari-
ous immune and inflammatory measures [8]. The “hy-
giene theory” of asthma etiology is predicated on this
basis [9]; and the environmental impact of the micro-
biome will also require consideration in the future [10].
Lastly, the population genetics of a community sets
the stage for this complex interaction between physi-
ology and environment. Differences in immune response
and inflammatory status have been seen in comparisons
between ethnic groups [11, 12] and more specifically
influenced by certain genetic variants [13, 14].
For all of the above reasons, we sought to obtain add-
itional information from an American Indian population,
comparing humoral immune factors among those with
and without asthma.
Methods
The measures reported here derive from a case–con-
trol study of the environmental and genetic influences
on risk of asthma among an American Indian popula-
tion in north-central United States. Most primary
medical care for this community of predominantly tri-
bal members is provided mainly by federal funding to
the Indian Health Service (IHS) and a tribal health
department. Specialty pulmonology or allergy medical
care is a minimum of 160 miles from the demo-
graphic center of the community.
This community is located in the north central portion
of South Dakota in an area covering 4266 square miles,
which is larger than the state of Connecticut. The area’s
population is about 8500, resulting in a population dens-
ity of between 2 and 3 people per square mile. Most live
in cluster housing near small towns or in cluster sites far
removed from basic services. Beyond federally supported
work in health care and education, ranching and farming
provide the bulk of employment. None the less, 33 and
42 % of two counties within this community have in-
comes below the poverty line, making them the 11th and
4th lowest per capita income counties in America re-
spectively. In addition, over 20 % have less than a high
school education [15].
Cases were ascertained through automated query of
the IHS electronic medical records system, searching for
an inclusive array of ICD-9 codes between 493.00 and
493.92, in addition to codes 786.07 (wheezing) and
V17.5 (family history of asthma). The search was limited
to individuals between and including the ages of 6 and
17 years. Additional cases were sought by contact with
local non-IHS providers. This identified over 700 indi-
viduals, who were then consented for further review of
medical records to determine potential eligibility.
Case definition criteria required at least 2 of the
following 3 criteria:
1) a diagnosis of asthma on at least 2 occasions by
more than one provider during the past 2 years.
2) refills of asthma treatment medications on at
least 2 occasions during the past 2 years.
3) If spirometry had been conducted, there was an
improvement in forced expired volume at one
second (FEV1) of 20 % with use of albuterol
metered-dose inhaler (MDI) or nebulizer
Exclusionary criteria were:
1) Birthweight less than 2500 g
2) Neonatal ventilator treatment
3) Hospitalization at birth greater than 15 days.
4) Congenital heart anomaly requiring surgery
5) Diagnosis of cystic fibrosis
6) Congenital lung, diaphragm, chest wall, or airway
anomaly
7) Diagnosis of pneumonia, pertussis, or tuberculosis
within the past year
8) Congenital muscular disorder
It was found that many of the potential cases initially
identified had been assigned an ICD-9 code indicating
“asthma” by the pharmacist filling a prescription for a
bronchodilator, although the prescribing physician had
not indicated a diagnosis of typical “asthma” and was
intending to ameliorate the bronchospastic component
of a pulmonary infection. These latter children did not
meet diagnostic criteria; but did require considerable
recruiter effort to contact parents and determine their
status via medical record review.
For each case, two controls were initially recruited
by identifying the two children born the day after and
before the index case and contacting the parents for
consent to review medical records for possible inclu-
sion. As the study progressed, this methodology
proved too time consuming and many controls were
later recruited from previously identified families with
children born almost exclusively (>99 %) within
6 months of the index case. Initial recruitment was
concentrated on cases and later focused on controls,
thus the inherent bias of controls being older at the
time of exam (even though birth dates were generally
within protocol limits) was increased, such that all
but 5 (2.3 %) of the pairs were examined within one
year of each other. Controls met the same exclusion-
ary criteria as cases in addition to:
1) No diagnosis of asthma by any provider during the
past 2 years.
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2) No prescriptions of any asthma meds during the
past 2 years.
3) If spirometry had been conducted, an FEV1 greater
than 80 % of the predicted value [16]
Consenting cases and controls were then examined
according to study protocol, which included anthropo-
morphic measures, spirometry, salivary DNA collection
and a non-fasting blood draw. Environmental measures
of home air quality and dust exposure were made.
The inflammatory and immune biomarkers reported
here are as follows:
1) complete blood count (CBC) done at the local IHS
laboratory using Abbott Laboratories dedicated
reagents on an Abbott CELL-DYN Ruby, Abbott
Laboratories, Abbott Park, IL. These were
accomplished within 8 h of drawing.
2) high sensitivity C-reactive protein (CRP) done at
Sanford Laboratories, Rapid City, SD, using a
particle enhanced immunoturbidimetric assay,
(Roche dedicated CRPHS reagent, catalog number
04628918190, Roche Diagnostics, Indianapolis, IN),
on a Roche Cobas 6000 instrument.
3) total IgE was done at Sanford Laboratories, Sioux
Falls, SD by Fluorescent Enzyme Immunoassay,
(ImmunoCAP dedicated reagents, catalog number
10-9319-01, Phadia AB, Uppsala, Sweden) on the
Phadia ImmunoCAP 250 instrument.
4) allergen specific IgE sensitive to dog and cat dander,
A alternata mold, D farinae mite, and B germanica
cockroach antigens. These measures were also
conducted at Sanford Laboratories, Sioux Falls,
SD by the same technique as the total IgE, using
ImmunoCAP dedicated reagents, catalog numbers
14-4110-01, 14-4109-01, 14-4106-01, 14-4108-01,
14-4224-01 respectively, Phadia AB, Uppsala,
Sweden).
A questionnaire collected social, demographic, and
medical history from both cases and controls, most of
which will be reported in the future. One question:
“Has a medical person ever said that your child had
hay fever or seasonal allergies?” sought to gauge
atopic symptomatology.
With the exception of age, the majority of variables
measured had non-normal distributions (e.g. skewed-
ness >1) and were natural log transformed prior to
hypothesis testing. All of the resulting distributions,
except those representing a quantitative value for spe-
cific IgE sensitization, exhibited a skewedness of less
than 0.685 after transformation. The distribution of
specific IgE values remain significantly skewed, even
after log-transformation (maximum skewedness of 3.6
for Alternaria), probably due to the large proportion
of measures below the detection limit. Descriptive
statistics report median, minima and maxima, and
95 % confidence intervals for non-normal variables.
Cases and controls were compared using McNemar
chi-square statistics for discrete variables and paired
t-test for continuous variables. Univariate and multi-
variate logistic regression was used to explore effects
of multiple biomarkers on risk of asthma. Specific IgE
levels were analyzed both as a dichotomized variable
(above or below the detection threshold) and as a continu-
ous variable, with those below the detection limit (0.35
kUA/L) assigned a value of 0.35 divided by the √2, as is
commonly done [17]. All models were adjusted for age, as
there was a significant difference between cases and con-
trols due to factors noted previously. Correlation results
are expressed as Pearson coefficients, rho (ρ). Descriptive
analyses were done using SPSS 13.0.1 (IBM Inc, Armonk,
NY). Logistic regression used LogXact-11 (Cytel Inc,
Cambridge, MA). Significance was considered demon-
strated at p < 0.05.
Results
The characteristics of cases and controls are shown and
compared in Table 1.
The significant difference in age between cases and
controls is probably due to a number of factors, as noted
in the methods section. The mean difference in age is
approximately 4 months; but for this reason all logistic
regression models were adjusted for age.
Notable differences between case and control
groups include body mass index (BMI), white blood
cell count (WBC), percent eosinophils, total IgE, and
specific IgE levels over the detectable limit for all
tested antigens. Among controls the geometric mean
total IgE was 88.23 kIU/L and the median was 89
kIU/L, with an interquartile range of 35.5 to 229.
There was no significant statistical association be-
tween a history of hayfever or seasonal allergy and
either atopy (as defined by at least one of the five
specific IgE assays) or total IgE. Among cases, 61 %
had at least one specific IgE above the detectable
limit, compared with only 28 % of controls.
Table 2 shows the results of univariate logistic regres-
sion models testing the association of various measures
with case/control status. Relationships between case/
control status and covariates were similar to those seen
in Table 1, except that age did not reach statistical sig-
nificance in this analysis. The specific IgE levels were an-
alyzed both as continuous and binary variables (more or
less than the detectable limit). All of the tested specific
allergens showed very significant association with
asthma in both binary analysis and quantitative analyses.
An ordinal variable comprised of the cumulative number
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of all of the five antigens above the detectable limit was
highly associated with case status (p = 0.001).
Results of multivariate logistic regression models are
found in Table 3. Covariates with significant association
in univariate analysis were entered into two models, with
and without the cumulative sensitization variable (CSV).
Inclusion of CSV negated the association of total IgE
with asthma status. Analysis of total IgE as a binary trait,
above and below the median, gave essentially equivalent
results.
Correlation between certain variables is present. Not
surprisingly age is positively correlated with BMI (ρ =
0.423, p = 0.001); and negatively correlated with % eosin-
ophils (ρ = −0.310, p = 0.001); but notably not correlated
with cumulative sensitization (ρ = 0.046, p = 0.411). Posi-
tive correlations are also seen between total IgE and cu-
mulative BMI, total IgE and CSV (ρ = 0.658, p = 0.001),
BMI and WBC (ρ = 0.349, p = 0.001); and total IgE and
% eosinophils (ρ = 0.392, p = 0.001).
Discussion
Asthma is a multifactorial condition with significant as-
sociated morbidity, mortality and public health conse-
quences for all populations [2]; but American Indian
communities in particular, due to geographic isolation
and the paucity of services [18–20]. Although asthma re-
sults in differing clinical presentations, historically, the
importance of immune factors has been recognized as
Table 1 Characteristics of cases and controls. Represented as count and percent of subgroup (N, %) or as median and interquartile
range (IQR). P value determined McNemar chi-squared test, or paired samples t test using natural log transformed measures
Cases Controls
N = 108 N = 216
Characteristic Median or N (%) Min - Max Median or N (%) Min - Max P value
95 % CI (mean) 95 % CI (mean)
Male, N (%) 57 (53 %) 43.4–63.2 109 (51 %) 57.1–43.8 0.634
Age (years) 11.81 6.1–17.9 12.12 6.1–18.3 0.001
11.4–12.2 11.7–12.6
BMI (kg/m2) 24.4 14.6–62.1 21.9 10.8–45.4 0.004
24.3–26.5 22.7–24.4
White Blood Cells (WBC) (X 1000) 7.30 3.3–16.5 6.80 2.7–14.7 0.001
7.2–7.9 6.7–7.1
PMNsa (% of WBC) 54.7 25.7–85.1 56.2 3.6–85.5 0.398
53.4–56.1 54.7–57.5
Lymphocytes (%) 30.9 9.0–65.6 30.8 12.0–54.8 0.797
30.4–32.8 30.2–35.5
Basophils (%) 1.3 0.5–6.3 1.5 0.3–17.0 0.273
1.4–1.6 1.5–1.9
Eosinophils (%) 4.1 0.3–22.3 2.7 0.1–27.2 0.002
4.8–5.6 3.3–4.2
CRP (mg/L) 1.12 0.35–17.2 1.07 0.36–74.4 0.254
2.0–2.8 1.4–3.5
IgEb (total, kU/L) 213 3.0–4473 89 2.0–2676 0.001
382.6–573.9 169.1–271.0
IgE, Alternariac 24 (22 %) 14.4–30.1 11 (5 %) 2.2–8.0 0.001
IgE, cat dander 34 (32 %) 22.7–40.2 17 (8 %) 4.3–11.5 0.001
IgE, cockroach 29 (27 %) 18.5–35.2 28 (13 %) 8.5–17.4 0.001
IgE, dust mite 40 (37 %) 27.9–46.1 39 (18 %) 12.9–23.2 0.001
IgE, dog dander 30 (28 %) 19.3–36.2 13 (6 %) 2.8–9.2 0.001
> one antigen over detection limit 66 (61 %) 51.9–70.3 61 (28 %) 22.2–34.2 0.001
History of hay fever or seasonal allergy 38 (36 %) 26.2–44.2 65 (32 %) 24.0–36.2 0.444
apolymorphonuclear leukocytes
btotal Immunoglobulin E
cantigen specific IgE (ie above minimum detection limit, <0.35 kUA/L)
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playing a key role [21]. A clearer understanding of the
immune factors influencing asthma offers the possibility
of further improvements in prevention, diagnosis and
control, beyond those seen in the latter from the in-
creased use of inhaled corticosteroid medications in
recent decades [22].
The findings of this case–control study among 324
American Indian children in the Northern Plains of
the United States are largely in accord with previous
evidence of increased biomarkers of inflammation and
specific, immune sensitization. We demonstrated in-
creased total IgE immunoglobulins among those with
asthma (although not in a multivariate model includ-
ing a measure of specific sensitization), as also re-
ported in studies of European [12, 23–25], Han
Chinese [26], African Americans and various Hispanic
populations [11, 27]. Other studies have been unable
to find an association between total IgE and asthma
[28] or found this association holds only among those
with atopic sensitization to specific antigens [29].
There is debate as to whether the increased IgE is in
the pathophysiologic pathway of asthma, or merely an
associated “epiphenomenon” [30, 31]; however this
cannot be answered by a cross-sectional study such
as the present. Differences in the activity of dendritic
cells and IgA response likely play a modulating role
in the immune effects of IgE and other downstream
contributors [32]. Lack of strong evidence relating
asthma and genetic factors that increase IgE levels is
also an argument against a mechanistic role for total
IgE [6, 30]; none the less, anti-IgE therapy appears to
ameliorate the symptoms of asthma [33].
The level of high sensitivity CRP did not show any
association with case–control status. This finding is
unexpected in light of various reports in the literature
[34, 35], although one report found elevated CRP levels
among infants protective for subsequent asthma, in ac-
cord with the “hygiene hypothesis” [36].
The present study also documents increased levels of
all leukocytes and specifically the proportion of eosino-
phils among those with asthma. However, these mea-
sures are not found to be independent factors in models
adjusting for total IgE or a cumulative measure of IgE
antibodies targeting putative asthma triggers. Whether
this represents different aspects of a common inflamma-
tory factor, or a more direct influence of IgE on eosino-
phils (or vice versa) is not clear. The literature has
focused primarily on the presence of total leukocytes
and eosinophils in bronchial washings; but there are
reports of increased numbers of both elements in per-
ipheral circulation as well [4, 37–39].
Table 2 Logistic regression analysis with adjustment for age
due to significant age difference between cases and controls.
Odds ratios indicate increased risk associated with a 1 unit
change in the natural log of continuous variables
Odds Ratio P-Value 95 % CI
Age (years) 0.968 0.377 0.90–1.04
Individual variables below, simultaneously adjusted for age
Gender (Female = 0, Male = 1) 1.083 0.736 0.68–1.72
Body Mass Index (kg/m2) 3.720a 0.006 1.46–9.45
CRP (mg/L) 1.143a 0.260 0.91–1.44
IgE (total, kU/L) 1.425a 0.001 1.20–1.69
White blood cell count (X1,000) 3.008a 0.01 1.26–7.20
PMN leukocytes 0.899a 0.836 0.33–2.45
Lymphocytes 0.947a 0.903 0.39–2.27
Eosinophils 1.520a 0.01 1.10–2.09
Basophils 0.753a 0.277 0.45–1.26
Alternaria (quant)b 1.765 a 0.001 1.34–2.32
Alternaria (binary)c 5.280 0.001 2.47–11.27
Cat dander (quant) 1.702a 0.001 1.36–2.14
Cat dander (binary) 5.432 0.001 2.86–10.32
Cockroach (quant) 1.612a 0.001 1.27–2.05
Cockroach (binary) 2.522 0.002 1.41–4.53
Mite (quant) 1.287a 0.02 1.04–1.59
Mite (binary) 2.751 0.001 1.63–4.66
Dog (quant) 2.360a 0.001 1.63–3.42
Dog (binary) 6.135 0.001 3.03–12.41
Cumulative sensitivityd 1.830 0.001 1.49–2.24
aodds ratio associated with the natural log transformed value of this measure
bIgE specific titer, samples below the detection limit of 0.35 were assigned
values of 0.35 /√2
cAny level above detection limit vs below detection limit
dNumber of antigens tested that showed specific IgE above detection limit for
that individual
Table 3 Two Multivariate logistic regression analyses with
adjustment for age, one including a cumulative measure of
specific sensitization and another without
Odds Ratio P-Value 95 % CI
Age (years) 0.910 0.059 0.83–1.00
Body Mass Index (kg/m2) 2.471a 0.114 0.81–7.58
IgE (total, kU/L) 0.997a 0.981 0.79–1.26
White blood cell count (X1,000) 1.907a 0.225 0.67–5.40
Eosinophils (%) 1.054a 0.782 0.73–1.53
Cumulative sensitivityb 1.751 0.001 1.33–2.30
Multivariate model without cumulative sensitivity
Age (years) 0.930 0.123 0.85–1.02
Body Mass Index (kg/m2) 2.700a 0.070 0.92–7.90
IgE (total, kU/L) 1.352a 0.001 1.12–1.63
White blood cell count (X1,000) 1.965a 0.180 0.73–5.28
Eosinophils (%) 1.158a 0.422 0.81–1.66
aodds ratio associated with the natural log transformed value of this measure
bNumber of antigens tested that showed specific IgE above detection limit for
that individual
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In the present study, IgE antibodies specific for the five
common environmental antigens tested are strongly as-
sociated with asthma. This is apparent for each of the
five antigens when analyzed as a binary variable (above
or below the limit of detection); and not surprisingly,
when a cumulative variable incorporating all of the anti-
gens was used. The increased risk of asthma in the pres-
ence of specific IgE antibodies is commonly reported in
the literature [25] and is frequently included in diagnos-
tic criteria for atopy [31] and “extrinsic” asthma [40]. Of
some interest is the comparison between reported preva-
lence of sensitization (at least one of 5 antigens above
the detection limit) in the present study (28 % among
controls) with controls from an Alaskan Native [28]
(18 %), a Swedish [41] study (3 %), and a US NHANES,
population-based sample (37 %) [29].
Although obviously not a humoral factor, univariate
analyses showed obesity was also positively associated
with asthma risk in this cohort, with each BMI unit con-
tributing approximately 5 % additional risk. The contri-
bution of BMI was attenuated in multivariate analyses;
but was still suggestive (p = 0.07) when a cumulative
measure of sensitization was excluded from the model.
The increased risk of asthma in the presence of obesity
is well established in the literature [42, 43]; and has been
previously demonstrated in an American Indian commu-
nity [44]. This appears to exemplify still one more aspect
of the complicated relationship between obesity and
inflammation [45].
While there are clearly numerous social and environ-
mental factors that influence the risk of asthma and its
complications, there also appear to be ethnic and genetic
influences at play [46, 47]. Due to differences in study
populations, comparisons invite caution; but the total
IgE geometric mean (GM) among controls in the
present study (89 kU/L), is above the GM for European
and African American controls in Michigan [12] (24.8
and 59.2 kU/L respectively), median non-atopic Green-
landic children (61 kU/L) [48], similar to a Japanese co-
hort (mean 81.3 kU/L) [49] and below the GM of an
Alaskan Native cohort (122.1 kU/L) [28]. In addition,
45.5 % of total IgE levels among controls are above the
reference range (20–100 kU/L) for the study lab. It has
been hypothesized that population-level regulation of
IgE may reflect historical, environmental exposures, for
example to parasitic infestation [50].
Conclusion
Evidence from this case–control study among an
American Indian population shows strong, independ-
ent association between increasing levels of specific
IgE sensitization to 5 common environmental anti-
gens and asthma, even after adjustment for other
widely accepted risk factors, such as obesity and total
IgE levels. The presence of elevated total IgE levels is
associated with asthma risk as expected, when there
is no adjustment for specific IgE sensitization. In light
of evidence that asthma risk is influenced by genetic vari-
ants, the current results complement our understanding
of asthma, especially as it relates to ethnicity.
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